CellProthera and Alfresa Holdings have signed an MOU covering potential [...]
Caristo Diagnostics’ CaRi-Heart technology has received US FDA De Novo [...]
CellProthera and Alfresa Holdings have signed an MOU covering potential [...]
Caristo Diagnostics’ CaRi-Heart technology has received US FDA De Novo [...]